# Baldwin Insurance Group, Inc.: filings

BWIN · Nasdaq · CIK 1781755 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bwin.md) · [Financials](/companies/bwin/financials.md) · [Filings](/companies/bwin/filings.md) · [Insiders](/companies/bwin/insiders.md)

## Reports and events: 129 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 455, 8-K 85, 144 65, 3 40, SC 13G/A 38, D 33, 10-Q 21, SC 13G 21, CORRESP 11, SCHEDULE 13G/A 11, DEFA14A 10, S-8 10, 3/A 8, 10-K 7, DEF 14A 7, SCHEDULE 13G 7, 8-K/A 5, UPLOAD 5, 424B5 4, ARS 4, 4/A 3, FWP 3, 144/A 2, 424B4 2, 8-A12B 2, CERT 2, DRS 2, EFFECT 2, S-1 2, S-1/A 2, S-3ASR 2, 424B7 1, D/A 1, DEF 14C 1, PRE 14C 1, PREM14A 1, SC 13E3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-09 | 16:07 ET | [8-K](/filings/0001781755-26-000058.md) | 9.01 Financial statements and exhibits | 0001781755-26-000058 |
| 2026-09-21 | 06:52 ET | [8-K](/filings/0001781755-26-000053.md) | 5.02 Departure or appointment of officers or directors | 0001781755-26-000053 |
| 2026-09-14 | 09:19 ET | [8-K](/filings/0000950103-26-013874.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-26-013874 |
| 2026-07-30 | 16:40 ET | [10-Q](/filings/0001781755-26-000049.md) | Quarterly report, period 2026-06-30 | 0001781755-26-000049 |
| 2026-07-30 | 16:11 ET | [8-K](/filings/0001781755-26-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-26-000047 |
| 2026-06-04 | 16:35 ET | [8-K](/filings/0001781755-26-000042.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001781755-26-000042 |
| 2026-05-04 | 16:54 ET | [10-Q](/filings/0001781755-26-000034.md) | Quarterly report, period 2026-03-31 | 0001781755-26-000034 |
| 2026-05-04 | 16:19 ET | [8-K](/filings/0001781755-26-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-26-000032 |
| 2026-04-22 | 17:05 ET | [DEF 14A](/filings/0001781755-26-000027.md) | Proxy statement, period 2026-06-04 | 0001781755-26-000027 |
| 2026-02-26 | 17:25 ET | [10-K](/filings/0001781755-26-000018.md) | Annual report, period 2025-12-31 | 0001781755-26-000018 |
| 2026-02-26 | 16:18 ET | [8-K](/filings/0001781755-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-26-000015 |
| 2026-01-02 | 08:41 ET | [8-K](/filings/0001781755-26-000005.md) | 9.01 Financial statements and exhibits | 0001781755-26-000005 |
| 2026-01-02 | 07:55 ET | [8-K](/filings/0001781755-26-000004.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001781755-26-000004 |
| 2025-12-02 | 17:04 ET | [8-K](/filings/0001781755-25-000114.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001781755-25-000114 |
| 2025-11-04 | 16:42 ET | [10-Q](/filings/0001781755-25-000109.md) | Quarterly report, period 2025-09-30 | 0001781755-25-000109 |
| 2025-11-04 | 16:15 ET | [8-K](/filings/0001781755-25-000107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-25-000107 |
| 2025-09-18 | 16:05 ET | [8-K](/filings/0001193125-25-207391.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-207391 |
| 2025-08-05 | 16:32 ET | [10-Q](/filings/0001781755-25-000096.md) | Quarterly report, period 2025-06-30 | 0001781755-25-000096 |
| 2025-08-05 | 16:12 ET | [8-K](/filings/0001781755-25-000094.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-25-000094 |
| 2025-06-06 | 16:06 ET | [8-K](/filings/0001781755-25-000076.md) | 5.07 Shareholder vote results | 0001781755-25-000076 |
| 2025-05-06 | 16:55 ET | [10-Q](/filings/0001781755-25-000063.md) | Quarterly report, period 2025-03-31 | 0001781755-25-000063 |
| 2025-05-06 | 16:16 ET | [8-K](/filings/0001781755-25-000060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-25-000060 |
| 2025-04-23 | 16:06 ET | [DEF 14A](/filings/0001781755-25-000052.md) | Proxy statement, period 2025-06-05 | 0001781755-25-000052 |
| 2025-02-25 | 16:57 ET | [10-K](/filings/0001781755-25-000017.md) | Annual report, period 2024-12-31 | 0001781755-25-000017 |
| 2025-02-25 | 16:09 ET | [8-K](/filings/0001781755-25-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-25-000015 |
| 2025-01-10 | 16:30 ET | [8-K](/filings/0000950103-25-000389.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0000950103-25-000389 |
| 2024-11-04 | 16:45 ET | [10-Q](/filings/0001781755-24-000093.md) | Quarterly report, period 2024-09-30 | 0001781755-24-000093 |
| 2024-11-04 | 16:08 ET | [8-K](/filings/0001781755-24-000091.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-24-000091 |
| 2024-10-31 | 18:40 ET | [8-K](/filings/0001781755-24-000086.md) | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001781755-24-000086 |
| 2024-08-06 | 16:24 ET | [10-Q](/filings/0001781755-24-000048.md) | Quarterly report, period 2024-06-30 | 0001781755-24-000048 |
| 2024-08-06 | 16:10 ET | [8-K](/filings/0001781755-24-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-24-000047 |
| 2024-06-06 | 16:23 ET | [8-K](/filings/0001781755-24-000035.md) | 5.07 Shareholder vote results | 0001781755-24-000035 |
| 2024-05-29 | 17:21 ET | [8-K](/filings/0001193125-24-149333.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-149333 |
| 2024-05-16 | 08:09 ET | [8-K](/filings/0001193125-24-140051.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-140051 |
| 2024-05-08 | 07:16 ET | [8-K](/filings/0001193125-24-133773.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-133773 |
| 2024-05-07 | 16:18 ET | [10-Q](/filings/0001781755-24-000030.md) | Quarterly report, period 2024-03-31 | 0001781755-24-000030 |
| 2024-05-07 | 16:07 ET | [8-K](/filings/0001781755-24-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-24-000028 |
| 2024-04-25 | 16:17 ET | [DEF 14A](/filings/0001193125-24-113925.md) | Proxy statement, period 2024-06-05 | 0001193125-24-113925 |
| 2024-02-28 | 16:30 ET | [10-K](/filings/0001781755-24-000016.md) | Annual report, period 2023-12-31 | 0001781755-24-000016 |
| 2024-02-28 | 16:08 ET | [8-K](/filings/0001781755-24-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-24-000014 |
| 2024-01-24 | 16:26 ET | [8-K](/filings/0001781755-24-000004.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001781755-24-000004 |
| 2023-11-07 | 16:24 ET | [10-Q](/filings/0001781755-23-000042.md) | Quarterly report, period 2023-09-30 | 0001781755-23-000042 |
| 2023-11-07 | 16:17 ET | [8-K](/filings/0001781755-23-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-23-000040 |
| 2023-09-19 | 16:30 ET | [8-K](/filings/0001781755-23-000032.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001781755-23-000032 |
| 2023-08-09 | 16:23 ET | [10-Q](/filings/0001781755-23-000027.md) | Quarterly report, period 2023-06-30 | 0001781755-23-000027 |
| 2023-08-09 | 16:10 ET | [8-K](/filings/0001781755-23-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-23-000025 |
| 2023-06-07 | 08:23 ET | [8-K](/filings/0001781755-23-000019.md) | 5.07 Shareholder vote results | 0001781755-23-000019 |
| 2023-05-09 | 16:26 ET | [8-K](/filings/0001781755-23-000015.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001781755-23-000015 |
| 2023-05-09 | 16:23 ET | [10-Q](/filings/0001781755-23-000014.md) | Quarterly report, period 2023-03-31 | 0001781755-23-000014 |
| 2023-05-09 | 16:15 ET | [8-K](/filings/0001781755-23-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001781755-23-000012 |

Page 1 of 3. [Older](/companies/bwin/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 09:03 ET. No prices; not investment advice.